Evaluation of bone turnover/quality markers and bone mineral density (BMD) in prostate cancer patients treated by androgen deprivation therapy with or without denosumab

被引：0
|
作者：
Miyazawa, Y. [1 ]
Syuto, T. [1 ]
Sekine, Y. [1 ]
Nomura, M. [1 ]
Koike, H. [1 ]
Matsui, H. [1 ]
Shibata, Y. [1 ]
Ito, K. [1 ]
Suzuki, K. [1 ]
机构：
[1] Gunma Univ, Urol, Maebashi, Gunma, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PP131
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] Effects of alendronate on bone mineral density in men with prostate cancer treated with androgen deprivation therapy.
    Bruder, JM
    Katselnik, D
    Wing, N
    Ma, JZ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S217 - S217
  • [22] Bone mineral density in Japanese prostate cancer patients under androgen-deprivation therapy
    Wang, Wei
    Yuasa, Takeshi
    Tsuchiya, Norihiko
    Maita, Shinya
    Kumazawa, Teruaki
    Inoue, Takamitsu
    Saito, Mitsuru
    Ma, Zhiyong
    Obara, Takashi
    Tsuruta, Hiroshi
    Satoh, Shigeru
    Habuchi, Tomonori
    ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 943 - 952
  • [23] Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
    Dalla Via, Jack
    Daly, Robin M.
    Owen, Patrick J.
    Mundell, Niamh L.
    Rantalainen, Timo
    Fraser, Steve F.
    BONE, 2019, 127 : 367 - 375
  • [24] RELATIONSHIP BETWEEN REDUCTION IN BONE TURNOVER MARKERS (BTM) AND CHANGE IN BONE MINERAL DENSITY (BMD) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH DENOSUMAB
    Eastell, R.
    Christiansen, C.
    Grauer, A.
    Kutilek, S.
    Libanati, C.
    McClung, M.
    Resch, H.
    Siris, E.
    Uebelhart, D.
    Reid, I.
    Wang, A.
    Weryha, G.
    Cummings, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 185 - 186
  • [25] The effect of androgen deprivation therapy (ADT) on bone mineral density (BMD) in men with prostate cancer: A meta-analysis
    Lau, A.
    Vinik, O.
    Alibhai, S. M. H.
    Tomlinson, G.
    Cheung, A. M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S141 - S141
  • [26] Decrease of bone mineral density in Japanese patients with non-metastatic prostate cancer treated with androgen deprivation therapy
    Seiichi Kato
    Makoto Kawase
    Daiki Kato
    Takashi Ishida
    Masahiro Uno
    Yoshinori Fujimoto
    Takako Masue
    Naruyasu Masue
    Takashi Deguchi
    Journal of Bone and Mineral Metabolism, 2019, 37 : 72 - 80
  • [27] Decrease of bone mineral density in Japanese patients with non-metastatic prostate cancer treated with androgen deprivation therapy
    Kato, Seiichi
    Kawase, Makoto
    Kato, Daiki
    Ishida, Takashi
    Uno, Masahiro
    Fujimoto, Yoshinori
    Masue, Takako
    Masue, Naruyasu
    Deguchi, Takashi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (01) : 72 - 80
  • [28] Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia
    Dagli, Mehmet
    Kutlucan, Ali
    Abusoglu, Sedat
    Basturk, Abdulkadir
    Sozen, Mehmet
    Kutlucan, Leyla
    Unlu, Ali
    Yilmaz, Farise
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (02) : 206 - 210
  • [29] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
    M. Kamimura
    Y. Nakamura
    S. Ikegami
    S. Uchiyama
    H. Kato
    A. Taguchi
    Osteoporosis International, 2017, 28 : 559 - 566
  • [30] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
    Kamimura, M.
    Nakamura, Y.
    Ikegami, S.
    Uchiyama, S.
    Kato, H.
    Taguchi, A.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (02) : 559 - 566
12345